Drug class · Endocrine & metabolism
Biguanides Drug Codes & NDCs
The biguanide class, which in current US listings is metformin alone or in fixed-dose combinations.
FDA-listed products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Synjardyempagliflozin and metformin hydrochloride | Empagliflozin 12.5 mg/1; Metformin hydrochloride 500 mg/1 | TabletOral | Boehringer Ingelheim Pharmaceuticals, Inc. | 0597-0180 |
| Synjardy XRempagliflozin, metformin hydrochloride | Empagliflozin 10 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Extended releaseOral | Boehringer Ingelheim Pharmaceuticals, Inc. | 0597-0280 |
| Synjardy XRempagliflozin, metformin hydrochloride | Empagliflozin 5 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Extended releaseOral | Boehringer Ingelheim Pharmaceuticals, Inc. | 0597-0290 |
| Synjardy XRempagliflozin, metformin hydrochloride | Empagliflozin 25 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Extended releaseOral | Boehringer Ingelheim Pharmaceuticals, Inc. | 0597-0295 |
| Synjardy XRempagliflozin, metformin hydrochloride | Empagliflozin 12.5 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Extended releaseOral | Boehringer Ingelheim Pharmaceuticals, Inc. | 0597-0300 |
| Trijardy XRempagliflozin, linagliptin, metformin hydrochloride | Empagliflozin 10 mg/1 + 2 more ingredients | Tablet, Extended releaseOral | Boehringer Ingelheim Pharmaceuticals, Inc. | 0597-0380 |
| Trijardy XRempagliflozin, linagliptin, metformin hydrochloride | Empagliflozin 12.5 mg/1 + 2 more ingredients | Tablet, Extended releaseOral | Boehringer Ingelheim Pharmaceuticals, Inc. | 0597-0385 |
| Trijardy XRempagliflozin, linagliptin, metformin hydrochloride | Empagliflozin 25 mg/1 + 2 more ingredients | Tablet, Extended releaseOral | Boehringer Ingelheim Pharmaceuticals, Inc. | 0597-0390 |
| Trijardy XRempagliflozin, linagliptin, metformin hydrochloride | Empagliflozin 5 mg/1 + 2 more ingredients | Tablet, Extended releaseOral | Boehringer Ingelheim Pharmaceuticals, Inc. | 0597-0395 |
| Xigduo XRdapagliflozin and metformin hydrochloride | Dapagliflozin propanediol 2.5 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coated, Extended releaseOral | AstraZeneca Pharmaceuticals LP | 0310-6225 |
| Xigduo XRdapagliflozin and metformin hydrochloride | Dapagliflozin propanediol 5 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coated, Extended releaseOral | AstraZeneca Pharmaceuticals LP | 0310-6250 |
| Xigduo XRdapagliflozin and metformin hydrochloride | Dapagliflozin propanediol 5 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coated, Extended releaseOral | AstraZeneca Pharmaceuticals LP | 0310-6260 |
| Xigduo XRdapagliflozin and metformin hydrochloride | Dapagliflozin propanediol 10 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coated, Extended releaseOral | AstraZeneca Pharmaceuticals LP | 0310-6270 |
| Xigduo XRdapagliflozin and metformin hydrochloride | Dapagliflozin propanediol 10 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coated, Extended releaseOral | AstraZeneca Pharmaceuticals LP | 0310-6280 |
| Zituvimetsitagliptin and metformin hydrochloride | Sitagliptin 50 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coatedOral | Zydus Pharmaceuticals (USA) Inc. | 70710-1786 |
| Zituvimetsitagliptin and metformin hydrochloride | Sitagliptin 50 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coatedOral | Zydus Pharmaceuticals (USA) Inc. | 70710-1787 |
| Zituvimetsitagliptin and metformin hydrochloride | Sitagliptin 50 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coatedOral | Zydus Lifesciences Limited | 70771-1859 |
| Zituvimetsitagliptin and metformin hydrochloride | Sitagliptin 50 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coatedOral | Zydus Lifesciences Limited | 70771-1860 |
| Zituvimet XRsitagliptin and metformin hydrochloride | Sitagliptin 50 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coated, Extended releaseOral | Zydus Pharmaceuticals USA Inc. | 70710-1804 |
| Zituvimet XRsitagliptin and metformin hydrochloride | Sitagliptin 50 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coated, Extended releaseOral | Zydus Pharmaceuticals USA Inc. | 70710-1805 |
| Zituvimet XRsitagliptin and metformin hydrochloride | Sitagliptin 100 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coated, Extended releaseOral | Zydus Pharmaceuticals USA Inc. | 70710-1806 |
| Zituvimet XRsitagliptin and metformin hydrochloride | Sitagliptin 50 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coated, Extended releaseOral | Zydus Lifesciences Limited | 70771-1879 |
| Zituvimet XRsitagliptin and metformin hydrochloride | Sitagliptin 50 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coated, Extended releaseOral | Zydus Lifesciences Limited | 70771-1880 |
| Zituvimet XRsitagliptin and metformin hydrochloride | Sitagliptin 100 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coated, Extended releaseOral | Zydus Lifesciences Limited | 70771-1881 |